This assay is to provide CCRF-CEM-based In Vitro TRAP Assay (Senescence) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
CCRF-CEM
Target Cell Organism
Human
Target Cell Background
CCRF-CEM [CCRF CEM] are human T lymphoblasts isolated from the peripheral blood of a female, Caucasian 4-year-old with acute lymphoblastic leukemia (ALL). This cell line is used for immuno-oncology and immunology research.
Target Cell Alternative Name
CCRF CEM
Related Diseases
Acute Lymphoblastic Leukemia; ALL
Research Area
Oncology
Assay Name
In Vitro TRAP Assay (Senescence)
Short Description
CCRF-CEM-cell based In Vitro TRAP Assay (Senescence)
Assay Description
The telomerase repeated amplification protocol (TRAP) assay is one of the common PCR-based assays used to detect telomerase activity in cells.
Assay Alternative Names
Telomerase Repeated Amplification Protocol Assay
Assay Type
Cellular Senescence in Cancer Assays
Assay Type Details
Cell senescence is described as an irreversible physiological event of cell growth arrest, which is known to be caused by alterations of telomeres, oxidative stress, DNA damage and some oncogenes. Inhibition of the program of senescence is one of the main features of tumor cells and it has been reported that cancer cells can be induced to undergo senescence by chemo- and radiotherapies and genetic alterations. Telomeres help to prevent uncontrolled cell proliferation and the absence of telomeres results in aneuploidy and cell death.